A new study conducted by a McMaster University medical researcher indicates that the correct type of drug therapy can curb type 2 diabetes.
The expert, Hertzel Gerstei, is a professor in the departments of medicine and clinical epidemiology and biostatistics. He presented his discovery in the Lancet, a leading UK medical journal, and also to the European Association for the Study of Diabetes in Copenhagen last month.
Gerstein examined 5,000 people throughout 21 countries who were at risk of developing diabetes. He found that those who took the drugs ramipril and rosiglatzone over a three year period could prevent or delay type 2 diabetes.
Gerstein said: “The trials showed that a drug used and approved to treat diabetes, rosiglitazone – which is sold under the brand name Avandia – can also prevent or delay diabetes when given to people at high risk of future diabetes.”
Gerstein was keen to stress that no drug was a ‘magic bullet’ prevention for diabetes. The traditional methods of preventing type 2 diabetes – eating a healthier diet and increasing exercise with the aim of losing weight were still necessary. The drugs, although not yet approved for diabetes prevention, could be a vital enhancer for some people in their fight against the disease .

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…